Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Evaluate the Safety, Pharmacokinetics of AD-118 and AD-1181 in Healthy Adult Subjects
Sponsor: Addpharma Inc.
Summary
A Study to Evaluate the Safety and Pharmacokinetics of AD-118 and AD-1181 Under Fasted Conditions in Healthy Adult Subjects
Official title: An Open-label, Randomized, Fasting, Single-dose, 2-sequence, 2-period, Crossover Study to Evaluate the Safety and the Pharmacokinetics of AD-118 Compared to AD-1181 in Healthy Adult Volunteers
Key Details
Gender
All
Age Range
19 Years - 64 Years
Study Type
INTERVENTIONAL
Enrollment
74
Start Date
2026-07-24
Completion Date
2026-08
Last Updated
2026-07-21
Healthy Volunteers
Yes
Conditions
Interventions
AD-118, AD-1181
Single-dose oral administration of AD-118, according to randomized treatment sequence in a 2-period crossover design.
AD-118, AD-1181
Single-dose oral administration of AD-1181, according to randomized treatment sequence in a 2-period crossover design.
Locations (1)
H Plus Yangji Hospital
Seoul, South Korea